| Date Filed | Type | Description |
| 10/05/2023 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 210,225 options to buy
@ $0.24, valued at
$50.5k
|
|
| 03/31/2023 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 41,065 options to buy
@ $1.05, valued at
$43.1k
|
|
| 10/07/2022 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 42,239 options to buy
@ $1.25, valued at
$52.8k
|
|
| 03/24/2022 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 21,878 options to buy
@ $1.92, valued at
$42k
|
|
| 10/07/2021 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 25,245 options to buy
@ $2.12, valued at
$53.5k
|
|
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2020 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.72, valued at
$18k
|
|
| 04/21/2020 |
3
| Auffarth Gerd (Director) has filed a Form 3 on Outlook Therapeutics, Inc. |
| 12/19/2018 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Presbia PLC|
Txns:
| Granted 81,743 options to buy
@ $0.53, valued at
$43.3k
|
|
| 07/20/2018 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Presbia PLC|
Txns:
| Granted 67,981 options to buy
@ $2, valued at
$136k
|
|
| 03/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/09/2016 |
4
| Auffarth Gerd (Director) has filed a Form 4 on Presbia PLC|
Txns:
| Granted 8,247 shares
@ $0 |
|